🔗 Permalink

Inventor profile of:

James B. McMahon

City:

Frederick, Maryland

Country:

United States

Published Applications:

Last publication date:

2018-04-05

Top Assignees for applications by James B. McMahon

The entities that hold a legal rights for patent applications filed by inventor McMahon James B.:

The United States of America, as represented by the Secretary, Department of Health and Human Services 7 Washington, DC United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 3 Bethesda, MD United States
The United States of America as Represented by the Department of Health and Human Services 2 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Ser. 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda, MD United States
The United States of America,as represented by the Secretary, Department of Health and Human Service 1 Bethesda, MD United States
Office of Technology Transfer 1 Rockville, MD United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
The United States of America, as represented by the Secretary, Dept. of Health & Human Services 1 Bethesda, MD United States

Recent patent applications by McMahon James B.

James B. McMahon from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-04-05

US20180093995A1

Chemistry; metallurgy

Hypoxia-inducible factor 1 (HIF-1) inhibitors

#2 | 2016-11-17

US20160333060A1

Chemistry; metallurgy

Anti-viral cnidarins

#3 | 2015-12-03

US20150342978A1

Human necessities

Method of inhibiting ABCG2 and related treatments

#4 | 2013-10-17

US20130274323A1

Chemistry; metallurgy

Method of inhibiting ABCG2 and other treatment methods

#5 | 2012-03-01

US20120053116A1

Chemistry; metallurgy

Scytovirin domain 1 related polypeptides

#6 | 2011-08-04

US20110190240A1

Chemistry; metallurgy

Nuclear factor kappa B pathway inhibitor composition and use of same

#7 | 2011-07-28

US20110183894A1

Human necessities

ANTIVIRAL ACTIVITY OF THE PROTEIN SCYTOVIRIN AND METHODS OF USE

#8 | 2010-12-16

US20100317732A1

Human necessities

Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

#9 | 2010-10-21

US20100267652A1

Human necessities

Method of inhibiting ABCG2 and related treatments

#10 | 2010-09-23

US20100240578A1

Human necessities

ANTI-H5N1 INFLUENZA ACTIVITY OF THE ANTIVIRAL PROTEIN CYANOVIRIN

#11 | 2010-09-02

US20100221242A1

Human necessities

Anti-viral griffithsin compounds, compositions and methods of use

#12 | 2008-12-18

US20080311125A1

Chemistry; metallurgy

Scytovirin domain 1 related polypeptides

#13 | 2006-01-17

US8969689

Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

InventorID:

488399 ⎘